| Title | Date | PubMed ID |
|---|
| Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening. | 2015 Nov 5 | 25772235 |
| Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth. | 2014 Aug 30 | 25115398 |
| 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27. | 2014 Jul 17 | 25032860 |
| Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein. | 2014 Jun | 24566088 |
| Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3). | 2014 Feb 1 | 24398380 |
| Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism. | 2014 Jan 23 | 24451478 |
| Pfkfb (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase) isoforms display a tissue-specific and dynamic expression during Xenopus laevis development. | 2013 Oct | 23623824 |
| Moderate grade hyperammonemia activates lactate dehydrogenase-4 and 6-phosphofructo-2-kinase to support increased lactate turnover in the brain slices. | 2013 Sep | 23703029 |
| Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer. | 2013 Aug | 23674815 |
| A role for inducible 6-phosphofructo-2-kinase in the control of neuronal glycolysis. | 2013 Jun | 23246158 |